Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Chronic Heart Failure

Free Subscription 24.11.2025 2 Am J Cardiol 1 Cardiol Clin 1 Cardiovasc Res 1 Circ Cardiovasc Interv 1 Circ Heart Fail 2 Eur Heart J 2 Heart 1 Hypertension 1 Int J Cardiol 4 J Card Fail 4 J Cardiol 1 J Cardiovasc Pharmacol 2 J Mol Cell Cardiol 1 N Engl J Med 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. WILKIE GL, Patel R, Kovell L, Whelan A, et al
   Maternal Cardiac and Perinatal Outcomes Among Pregnant Individuals With Ebstein's Anomaly.
   Am J Cardiol. 2025;256:45-48.
   PubMed         Abstract available
   
   
2. YANO M, Egami Y, Kobayashi N, Sugino A, et al
   Phenotypic analysis of persistent atrial fibrillation focusing on post-ablation prognosis using brain natriuretic peptide-related factors.
   Am J Cardiol. 2025 Jul 14:S0002-9149(25)00408.
   PubMed         Abstract available
   
   

   
   Cardiol Clin

3. EL ROUMI J, Xu B
   Role of Multimodality Imaging in the Evaluation and Management of Cardiomyopathy and Heart Failure.
   Cardiol Clin. 2026;44:53-64.
   PubMed         Abstract available
   
   

   
   Cardiovasc Res

4. MATSUMOTO S, Butt JH, Docherty KF, Jhund PS, et al
   Obesity, aldosterone, and natriuretic peptide in patients with heart failure and reduced ejection fraction.
   Cardiovasc Res. 2025 Nov 18:cvaf235. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Interv

5. MOSARLA RC, Hochman JS, Axel L, Ramasamy R, et al
   Current Concepts in Revascularization for Ischemic Heart Disease With Reduced Ejection Fraction.
   Circ Cardiovasc Interv. 2025 Sep 15:e014625.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

6. MOELLER CM, Fernandez Valledor A, Oren D, Rahman S, et al
   Significance of Elevated Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Negative Endomyocardial Biopsies: A Dawn of a New Era.
   Circ Heart Fail. 2025 Sep 30:e012787. doi: 10.1161/CIRCHEARTFAILURE.125.012787.
   PubMed         Abstract available
   
   

   
   Eur Heart J

7. TAHARA N, Ohta K, Fukumoto Y
   Papillary muscle 18F-fluorodeoxyglucose uptake in heart failure with recovered ejection fraction: reversible metabolic remodelling mimicking cardiac sarcoidosis.
   Eur Heart J. 2025 Nov 18:ehaf898. doi: 10.1093.
   PubMed        
   
   
8. NITSCHE C, Dobner S, Rosenblum HR, Patel KP, et al
   Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis.
   Eur Heart J. 2025 Jun 2:ehaf362. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Heart

9. SHOJI S, Wilson N, Levitan EB, Judd SE, et al
   Isolated non-specific electrocardiographic ST-T abnormalities and risk of incident heart failure and its subtypes.
   Heart. 2025 Nov 17:heartjnl-2025-326798. doi: 10.1136/heartjnl-2025-326798.
   PubMed         Abstract available
   
   
10. MONZO L, Huttin O, Bozkurt B, Duarte K, et al
    Comparing diagnostic tools for heart failure with preserved ejection fraction across community and clinical cohorts.
    Heart. 2025 Nov 17:heartjnl-2025-326517. doi: 10.1136/heartjnl-2025-326517.
    PubMed         Abstract available
    
    

    
    Hypertension

11. KARIO K, Okawara Y, Kanegae H, Tomitani N, et al
    Relationship Between Home Blood Pressure Monitoring-Confirmed Resistant Hypertension and Cardiovascular Prognosis.
    Hypertension. 2025 Oct 23. doi: 10.1161/HYPERTENSIONAHA.125.25747.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

12. ASTENGO M, Lindow T, Bobbio E, Bollano E, et al
    Echocardiographic grading of right ventricular dysfunction improves risk stratification of patients with severe heart failure.
    Int J Cardiol. 2025 Nov 17:134026. doi: 10.1016/j.ijcard.2025.134026.
    PubMed         Abstract available
    
    

    
    J Card Fail

13. GORODESKI EZ, Shekhar S, Montgomery RA
    Letter to the Editor Reply: "The Advanced Heart Failure Workforce Crisis: A Path Forward".
    J Card Fail. 2025 Nov 12:S1071-9164(25)00993.
    PubMed        
    
    
14. GUGLIN M
    The Advanced Heart Failure Workforce Crisis: A Path Forward.
    J Card Fail. 2025 Nov 12:S1071-9164(25)00992.
    PubMed        
    
    
15. PACKER M
    Is It Time to Abandon Phenomapping of Heterogeneity to Elucidate the Mechanisms or Define the Treatment of Heart Failure with a Preserved Ejection Fraction?
    J Card Fail. 2025 Nov 12:S1071-9164(25)00990.
    PubMed        
    
    
16. PALO KED, Tiwari SC, DiDomenico RJ
    It takes a village: integrating the interdisciplinary heart failure team to optimize guideline-directed medical therapy.
    J Card Fail. 2025 Nov 19:S1071-9164(25)01025.
    PubMed        
    
    

    
    J Cardiol

17. MA Z
    Author's reply: Impact of congestive heart failure on early fluid administration and mortality in patients with Sepsis.
    J Cardiol. 2025 Nov 16:S0914-5087(25)00280-1. doi: 10.1016/j.jjcc.2025.
    PubMed        
    
    
18. YAGINUMA H, Saito Y, Asada K, Goto H, et al
    Combined prognostic impact of diabetes, chronic kidney disease, and heart failure after acute myocardial infarction.
    J Cardiol. 2025 Nov 12:S0914-5087(25)00279-5. doi: 10.1016/j.jjcc.2025.
    PubMed        
    
    
19. QIAN D, Wang H, Wang J
    Daprodustat in heart failure and renal anemia: Still early, but promising.
    J Cardiol. 2025 Nov 12:S0914-5087(25)00278-3. doi: 10.1016/j.jjcc.2025.
    PubMed        
    
    
20. PHAM HN, Ibrahim R, Mee XC, Lim GK, et al
    SGLT2 inhibitors and cardiovascular outcomes in patients with left ventricular assist devices.
    J Cardiol. 2025;86:425-434.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

21. XIE Y, Huang T, Wang H, Yang J, et al
    Lactylation-Related Gene Signature and Immune Infiltration Crosstalk in Heart Failure: Insights from Bulk and Single-Cell Transcriptomics.
    J Cardiovasc Pharmacol. 2025 Nov 18. doi: 10.1097/FJC.0000000000001775.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

22. MILLER JA, Moise N, Mendez MJ, Weinberg SH, et al
    Interplay between variability in intrinsic cellular properties and heart failure-associated remodeling in a simulated population with human heart failure.
    J Mol Cell Cardiol. 2025 Nov 18:S0022-2828(25)00212.
    PubMed         Abstract available
    
    
23. ZHANG M, Chen C, Liu X, Zhou Z, et al
    Soluble epoxide hydrolase deficiency rescues heart failure with preserved ejection fraction by targeting cytochrome P450 2E1.
    J Mol Cell Cardiol. 2025;210:98-108.
    PubMed         Abstract available
    
    

    
    N Engl J Med

24. JONS C, Zheng C, Winslow UCG, Danielsen EM, et al
    Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias.
    N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2509542.
    PubMed         Abstract available
    
    

    
    PLoS One

25. SHIN I, Bhatt N, Alashi A, Kandala K, et al
    Predicting 30-day and 1-year mortality in heart failure with preserved ejection fraction (HFpEF).
    PLoS One. 2025;20:e0336809.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.